Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nedaplatin vs Cisplatin with Docetaxel in Advanced Lung Squamous Cell Carcinoma
NCT02088515Phase 4Completed
- Sponsor
- Simcere Pharmaceutical Group
- Start
- Dec 2013
- Primary completion
- Oct 2016
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of nedaplatin in squamous cell carcinoma of the lung (SCCL), sponsored by Simcere Pharmaceutical Group. Started Dec 2013; status: completed.
02
Drugs
nedaplatin
03
Conditions
squamous cell carcinoma of the lung (SCCL)
Beyond the preview
Go deeper on NCT02088515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02088515.